Heron Therapeutics, Inc. /De/

MetLife Investment Management, LLC HRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

87,754

Value ($000)

114

Weight

0.0%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	114	0.0%	87,754	12/31/2025
2025 Q3	11/13/2025	116	0.0%	92,426	9/30/2025
2025 Q2	8/13/2025	191	0.0%	92,426	6/30/2025
2025 Q1	5/14/2025	120	0.0%	54,688	3/31/2025
2024 Q4	2/13/2025	111	0.0%	72,690	12/31/2024
2024 Q3	11/13/2024	143	0.0%	72,055	9/30/2024
2024 Q2	8/13/2024	252	0.0%	72,055	6/30/2024
2024 Q1	5/14/2024	111	0.0%	40,111	3/31/2024
2023 Q4	4/22/2024	91	0.0%	53,564	12/31/2023
2023 Q3	5/9/2024	55	0.0%	53,564	9/30/2023
2023 Q2	4/29/2024	62	0.0%	53,564	6/30/2023
2023 Q1	5/9/2024	81	0.0%	53,564	3/31/2023
2022 Q4	5/10/2024	134	0.0%	53,564	12/31/2022
2022 Q3	5/10/2024	226	0.0%	53,564	9/30/2022
2022 Q2	5/10/2024	149	0.0%	53,564	6/30/2022
2022 Q1	5/10/2024	306	0.0%	53,564	3/31/2022
2021 Q4	5/17/2024	299	0.0%	32,773	12/31/2021
2021 Q3	5/17/2024	350	0.0%	32,773	9/30/2021
2021 Q2	5/17/2024	509	0.0%	32,773	6/30/2021
2021 Q1	5/17/2024	531	0.0%	32,773	3/31/2021
2020 Q4	5/24/2024	827	0.0%	39,074	12/31/2020
2020 Q3	5/24/2024	579	0.0%	39,074	9/30/2020
2020 Q2	5/24/2024	575	0.0%	39,074	6/30/2020
2020 Q1	7/12/2023	429	0.0%	36,544	3/31/2020
2019 Q4	7/12/2023	859	0.0%	36,544	12/31/2019
2019 Q3	7/12/2023	626	0.0%	33,841	9/30/2019
2019 Q2	7/12/2023	629	0.0%	33,841	6/30/2019
2019 Q1	7/13/2023	718	0.0%	29,366	3/31/2019
2018 Q4	7/13/2023	762	0.0%	29,366	12/31/2018
2018 Q3	7/13/2023	929	0.0%	29,366	9/30/2018